(AZO) AutoZone - Ratings and Ratios
Automotive Parts, Accessories, Fluids, Tools, Software
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 21.2% |
| Value at Risk 5%th | 34.7% |
| Relative Tail Risk | -0.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.77 |
| Alpha | 14.89 |
| CAGR/Max DD | 0.88 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.405 |
| Beta | 0.161 |
| Beta Downside | 0.124 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.88% |
| Mean DD | 5.04% |
| Median DD | 4.16% |
Description: AZO AutoZone December 03, 2025
AutoZone, Inc. (NYSE: AZO) is a leading retailer and distributor of automotive replacement parts and accessories across the United States, Mexico, and Brazil. Its product portfolio spans new and remanufactured hard parts, maintenance items, and a broad range of non-automotive goods, sold through a network of over 6,600 stores and multiple e-commerce channels, including the ALLDATA diagnostic software platform and the Duralast private-label line.
In FY 2023 the company generated roughly $13.7 billion in revenue, delivering a 5.2% same-store sales increase and an operating margin near 15%, underscoring the resilience of the DIY automotive repair segment. Key economic drivers include rising vehicle-miles-travelled (VMT) as the U.S. fleet ages, and a modest inflation-adjusted price-elasticity that allows AutoZone to maintain pricing power while consumers defer dealership service. The sector benefits from a low-capex business model and strong cash conversion, which supports its ongoing share-repurchase program.
For a deeper, data-driven assessment of AZO’s valuation and risk profile, you may find the analyst notes on ValueRay worth reviewing.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (2.62b TTM) > 0 and > 6% of Revenue (6% = 1.17b TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -2.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -6.06% (prev -7.61%; Δ 1.56pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 3.12b > Net Income 2.62b (YES >=105%, WARN >=100%) |
| Net Debt (11.91b) to EBITDA (3.38b) ratio: 3.52 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (17.2m) change vs 12m ago -1.20% (target <= -2.0% for YES) |
| Gross Margin 52.40% (prev 53.09%; Δ -0.70pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 106.5% (prev 107.6%; Δ -1.16pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 6.07 (EBITDA TTM 3.38b / Interest Expense TTM 478.3m) >= 6 (WARN >= 3) |
Altman Z'' -0.20
| (A) -0.06 = (Total Current Assets 8.34b - Total Current Liabilities 9.52b) / Total Assets 19.36b |
| (B) -0.21 = Retained Earnings (Balance) -3.98b / Total Assets 19.36b |
| (C) 0.16 = EBIT TTM 2.90b / Avg Total Assets 18.27b |
| (D) -0.19 = Book Value of Equity -4.26b / Total Liabilities 22.77b |
| Total Rating: -0.20 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.71
| 1. Piotroski 3.50pt |
| 2. FCF Yield 2.37% |
| 3. FCF Margin 9.20% |
| 4. Debt/Equity -3.57 |
| 5. Debt/Ebitda 3.52 |
| 6. ROIC - WACC (= 42.61)% |
| 7. RoE -63.41% |
| 8. Rev. Trend 54.19% |
| 9. EPS Trend -30.27% |
What is the price of AZO shares?
Over the past week, the price has changed by -2.88%, over one month by +4.48%, over three months by -9.27% and over the past year by +20.39%.
Is AZO a buy, sell or hold?
- Strong Buy: 17
- Buy: 6
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the AZO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 4579.1 | 19.2% |
| Analysts Target Price | 4579.1 | 19.2% |
| ValueRay Target Price | 4198.1 | 9.3% |
AZO Fundamental Data Overview December 05, 2025
P/E Trailing = 26.3595
P/E Forward = 25.5754
P/S = 3.364
P/B = 13.383
P/EG = 2.0351
Beta = 0.41
Revenue TTM = 19.45b USD
EBIT TTM = 2.90b USD
EBITDA TTM = 3.38b USD
Long Term Debt = 8.80b USD (from longTermDebt, last quarter)
Short Term Debt = 283.6m USD (from shortTermDebt, last quarter)
Debt = 12.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.91b USD (from netDebt column, last quarter)
Enterprise Value = 75.61b USD (63.71b + Debt 12.18b - CCE 271.8m)
Interest Coverage Ratio = 6.07 (Ebit TTM 2.90b / Interest Expense TTM 478.3m)
FCF Yield = 2.37% (FCF TTM 1.79b / Enterprise Value 75.61b)
FCF Margin = 9.20% (FCF TTM 1.79b / Revenue TTM 19.45b)
Net Margin = 13.46% (Net Income TTM 2.62b / Revenue TTM 19.45b)
Gross Margin = 52.40% ((Revenue TTM 19.45b - Cost of Revenue TTM 9.26b) / Revenue TTM)
Gross Margin QoQ = 51.52% (prev 52.72%)
Tobins Q-Ratio = 3.91 (Enterprise Value 75.61b / Total Assets 19.36b)
Interest Expense / Debt = 1.22% (Interest Expense 148.1m / Debt 12.18b)
Taxrate = 20.14% (211.0m / 1.05b)
NOPAT = 2.32b (EBIT 2.90b * (1 - 20.14%))
Current Ratio = 0.88 (Total Current Assets 8.34b / Total Current Liabilities 9.52b)
Debt / Equity = -3.57 (negative equity) (Debt 12.18b / totalStockholderEquity, last quarter -3.41b)
Debt / EBITDA = 3.52 (Net Debt 11.91b / EBITDA 3.38b)
Debt / FCF = 6.65 (Net Debt 11.91b / FCF TTM 1.79b)
Total Stockholder Equity = -4.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.53% (Net Income 2.62b / Total Assets 19.36b)
RoE = -63.41% (negative equity) (Net Income TTM 2.62b / Total Stockholder Equity -4.13b)
RoCE = 62.17% (EBIT 2.90b / Capital Employed (Equity -4.13b + L.T.Debt 8.80b))
RoIC = 48.31% (NOPAT 2.32b / Invested Capital 4.80b)
WACC = 5.71% (E(63.71b)/V(75.89b) * Re(6.61%) + D(12.18b)/V(75.89b) * Rd(1.22%) * (1-Tc(0.20)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.93%
[DCF Debug] Terminal Value 76.53% ; FCFE base≈1.85b ; Y1≈1.65b ; Y5≈1.40b
Fair Price DCF = 1522 (DCF Value 25.31b / Shares Outstanding 16.6m; 5y FCF grow -13.12% → 3.0% )
EPS Correlation: -30.27 | EPS CAGR: -41.96% | SUE: -4.0 | # QB: 0
Revenue Correlation: 54.19 | Revenue CAGR: 15.23% | SUE: 0.02 | # QB: 0
EPS next Quarter (2026-02-28): EPS=28.78 | Chg30d=+0.239 | Revisions Net=-3 | Analysts=22
EPS current Year (2026-08-31): EPS=151.66 | Chg30d=-1.059 | Revisions Net=-3 | Growth EPS=+4.7% | Growth Revenue=+8.2%
EPS next Year (2027-08-31): EPS=181.87 | Chg30d=-0.187 | Revisions Net=+1 | Growth EPS=+19.9% | Growth Revenue=+6.6%
Additional Sources for AZO Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle